B cells maintain the homeostasis of splenic marginal zone antigen-presenting cells to promote the antiviral CD8+ T-cell response
簡介:
- 作者: Xinyuan Liu, Filiz Demircik, Mariia Antipova, Emmanouil Stylianakis, Matthias Klein, David Bejarano, Abdelrahman Elwy, Anna Ebering, Michaela Blanfeld, Katlynn Carter, Lisa Johann, David C. Uhlfelder, Elisa Blickberndt, Yao Chen, Hans Christian Probst, Nadine H?velmeyer, Tobias Bopp, Ramon Arens, Lukas Bunse, Joke M. M. den Haan, Jennifer L. Gommerman, Esther von Stebut, Bj?rn E. Clausen, Andreas Schlitzer, Karl S. Lang, Bing Su, Ronald A. Backer, Niels A. Lemmermann & Ari Waisman
- 雜志: Cellular & Molecular Immunology
- Doi: https://www.doi.org/10.1038/s41423-026-01392-0
- 出版日期: 2026/2/24
摘要
Natural killer and CD8+ T cells are critical in the elimination of blood-borne viruses such as cytomegalovirus (CMV); however, the role of B cells in this process is less clear. Here, using a murine CMV (MCMV) infection model, we demonstrated that B-cell-deficient mice mounted a weaker primary virus-specific CD8+ T-cell response than their wild-type counterparts did, which was associated with increased viral transcription. Notably, we found that the contribution of B cells to the CD8+ T-cell-mediated antiviral response was not associated with their ability to generate antibodies but with their ability to sustain Langerin+ type 1 conventional dendritic cells (cDC1s), a dendritic cell (DC) subset known for being involved in viral and bacterial clearance in the marginal zone of the spleen. Furthermore, we found that the presence of Langerin+ cDC1s is dependent on B cells expressing lymphotoxin (LTβ) to maintain CD169+ marginal metallophilic macrophages (MMMs). We further discovered, via ligand?receptor interaction analyses, that the communication between MMMs and Langerin+ cDC1s was mediated via the VCAM1–ITGA4/ITGB1 interaction. Thus, our data reveal that B cells regulate the development of MMMs in the spleen via LTβ expression and consequently sustain Langerin+ cDC1 homeostasis for effective initiation of an antiviral CD8+ T-cell response. Overall, our study offers a new perspective on how B cells maintain the homeostasis of antigen-presenting cells in the splenic marginal zone and thus indirectly affect the virus-specific CD8+ T-cell response, which could be extended to other infectious and autoimmune diseases as well as tumors.
關于派真
作為一家專注于AAV 技術十余年,深耕基因治療領域的CRO&CDMO,派真生物可提供從載體設計、構建到 AAV、慢病毒和 mRNA 服務的一站式解決方案。憑借深厚的技術實力、卓越的運營管理和高標準的服務交付,我們為全球客戶提供一站式CMC解決方案,包括從早期概念驗證、成藥性評估到IIT、IND及BLA的各個階段。
?
憑借我們獨立知識產權的π-alphaTM 293 細胞AAV高產技術平臺,我們能將AAV產量提高多至10倍,每批次產量可達1×101?vg,以滿足多樣化的商業化和臨床項目需求。此外,我們定制化的mRNA和脂質納米顆粒(LNP)產品及服務覆蓋藥物和疫苗開發的各個階段,從研發到符合GMP的生產,提供端到端的一站式解決方案。